Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

American Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$1,648,976

3,351 payments

Through program year 2025, American Clinical Trials is reported as receiving $1,648,976 in research payments, across 3,351 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $95,407 49
2024 Research $455,177 192
2023 Research $49,623 264
2022 Research $79,745 260
2021 Research $461,165 2,148
2020 Research $106,535 243
2019 Research $401,324 195

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $906,743 2,710 payments
  2. Alnylam Pharmaceuticals Inc. $352,820 615 payments
  3. Novartis Pharmaceuticals Corporation $241,155 8 payments
  4. Sanofi US Services Inc. $89,743 15 payments
  5. Shionogi Inc $54,590 2 payments
  6. Amarin Pharma Inc. $3,924 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) $293,119 46 payments
  2. Nn1436-4477 $202,239 1,000 payments
  3. A Multi-Center, Randomized, Double-Blind, Parallel-Group, 20-Week Dose-Finding Study to Evaluate Efficacy, Safety, and Tolerability of Xxb750 in Patients With Resistant Hypertension $174,649 3 payments
  4. Nn1250-4252 $138,568 4 payments
  5. Nn9535-4506 $103,805 182 payments
  6. Nn1436-4478 $100,734 386 payments
  7. Nn9536-4374 $95,407 72 payments
  8. Nn9924-4635 $83,289 91 payments
  9. Nn1436-4481 $76,090 477 payments
  10. A multi-center, randomized, double-blind placebo-controlled and open-label active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure $62,960 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record